ALTOPREV Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Altoprev, and what generic alternatives are available?
Altoprev is a drug marketed by Covis and is included in one NDA.
The generic ingredient in ALTOPREV is lovastatin. There are thirty-three drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the lovastatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Altoprev
A generic version of ALTOPREV was approved as lovastatin by ACTAVIS ELIZABETH on December 17th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALTOPREV?
- What are the global sales for ALTOPREV?
- What is Average Wholesale Price for ALTOPREV?
Summary for ALTOPREV
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 126 |
Clinical Trials: | 6 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ALTOPREV |
What excipients (inactive ingredients) are in ALTOPREV? | ALTOPREV excipients list |
DailyMed Link: | ALTOPREV at DailyMed |
Recent Clinical Trials for ALTOPREV
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Brigham and Women's Hospital | Phase 4 |
Amgen | Phase 4 |
Autoimmunity Centers of Excellence | Phase 2 |
Pharmacology for ALTOPREV
Drug Class | HMG-CoA Reductase Inhibitor |
Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
US Patents and Regulatory Information for ALTOPREV
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-001 | Jun 26, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-004 | Jun 26, 2002 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-002 | Jun 26, 2002 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-003 | Jun 26, 2002 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALTOPREV
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-002 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-001 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-003 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-004 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-001 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-003 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALTOPREV
See the table below for patents covering ALTOPREV around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 3200999 | ⤷ Sign Up | |
Japan | 4646400 | ⤷ Sign Up | |
Canada | 2324999 | ⤷ Sign Up | |
Australia | 759257 | ⤷ Sign Up | |
United Kingdom | 2371748 | HMG-COA reductase inhibitor extended release formulation | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9948488 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |